Soluble ICAM-1 activates lung macrophages and enhances lung injury

H Schmal1, B J Czermak, A B Lentsch

  • 1Department of Traumatology, University of Freiburg, Germany.

Insights

Soluble rat ICAM-1 (sICAM-1) activates alveolar macrophages, increasing inflammatory mediators TNF-alpha and MIP-2. This exacerbates lung injury by promoting neutrophil recruitment, highlighting ICAM-1

Area of Science:

  • Immunology
  • Pulmonology
  • Cell Biology

Background:

  • Intercellular Adhesion Molecule-1 (ICAM-1) plays a critical role in lung inflammatory injury.
  • Soluble recombinant rat ICAM-1 (sICAM-1) was produced to investigate its biological activities.
  • Understanding ICAM-1's function is crucial for developing therapeutic strategies against lung inflammation.

Purpose of the Study:

  • To evaluate the biological activities of soluble recombinant rat ICAM-1 (sICAM-1).
  • To determine the role of sICAM-1 in alveolar macrophage activation and lung inflammatory responses.
  • To investigate the signaling pathways involved in sICAM-1-mediated macrophage activation.

Main Methods:

  • Bacterial expression and purification of sICAM-1.
  • In vitro assays measuring sICAM-1 binding to alveolar macrophages and cytokine production (TNF-alpha, MIP-2).
  • Analysis of NF-kappaB activation, beta2 integrin engagement, and adherence.
  • In vivo studies involving airway instillation of sICAM-1 to assess lung injury.

Main Results:

  • Purified sICAM-1 bound to rat alveolar macrophages dose-dependently, inducing TNF-alpha and MIP-2 production.
  • sICAM-1 induced NF-kappaB activation, which was inhibited by proteasome and tyrosine kinase inhibitors.
  • Airway instillation of sICAM-1 intensified IgG immune complex-induced lung injury, associated with increased inflammatory mediators and neutrophil recruitment.

Conclusions:

  • Soluble rat ICAM-1 engages beta2 integrins on alveolar macrophages, enhancing the production of MIP-2 and TNF-alpha.
  • This activation of macrophages by sICAM-1 leads to intensified lung injury following immune complex deposition.
  • sICAM-1 represents a potential therapeutic target for modulating lung inflammatory responses.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...